ALGS
NASDAQ · Biotechnology
Aligos Therapeutics Inc
$6.89
+0.12 (+1.77%)
Open$6.77
Previous Close$6.77
Day High$6.97
Day Low$6.58
52W High$13.69
52W Low$3.98
Volume—
Avg Volume210.6K
Market Cap42.28M
P/E Ratio—
EPS$-8.70
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
-10.2% upside
Current
$6.89
$6.89
Target
$6.19
$6.19
$4.22
$6.19 avg
$8.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.36M | 2.51M | 10.09M |
| Net Income | -15,017,369 | -25,047,502 | -1,613,644 |
| Profit Margin | -1,106.7% | -1,051.4% | -16.0% |
| EBITDA | -54,036,758 | -95,135,137 | -2,029,249 |
| Free Cash Flow | — | — | -1,586,727 |
| Rev Growth | -46.0% | -46.0% | -9.4% |
| Debt/Equity | 0.00 | 0.00 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |